Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PG(40:5) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 30.1 | pmol/sample |
| - | PG(40:5) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 22 | pmol/sample |
| - | PG(40:5) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 12 | pmol/sample |
| - | PG(40:5) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 39.1 | pmol/sample |
| - | PG(40:5) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 37.9 | pmol/sample |
| - | PG(40:5) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 36.4 | pmol/sample |
| - | PG(40:5) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 25.9 | pmol/sample |
| - | PG(40:5) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 13.4 | pmol/sample |
| - | PG(40:5) | C | 0.0 | BCD100322A01 | 50.1 | pmol/sample |
| - | PG(40:5) | C | 0.5 | BCD100322A03 | 19.4 | pmol/sample |
| - | PG(40:5) | C | 1.0 | BCD100322A07 | 23 | pmol/sample |
| - | PG(40:5) | C | 2.0 | BCD100322A11 | 26.1 | pmol/sample |
| - | PG(40:5) | C | 4.0 | BCD100322A15 | 51 | pmol/sample |
| - | PG(40:5) | C | 8.0 | BCD100322A19 | 58.4 | pmol/sample |
| - | PG(40:5) | C | 12.0 | BCD100322A23 | 50 | pmol/sample |
| - | PG(40:5) | C | 24.0 | BCD100322A27 | 25.4 | pmol/sample |
| - | PG(40:5) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 12.2 | pmol/sample |
| - | PG(40:5) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 18.3 | pmol/sample |
| - | PG(40:5) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 21.1 | pmol/sample |
| - | PG(40:5) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 37.5 | pmol/sample |
| - | PG(40:5) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 33 | pmol/sample |
| - | PG(40:5) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 14.1 | pmol/sample |
| - | PG(40:5) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 7.54 | pmol/sample |
| - | PG(40:5) | 25OH-Chol | 0.5 | BCD100322A04 | 22.6 | pmol/sample |
| - | PG(40:5) | 25OH-Chol | 1.0 | BCD100322A08 | 14.6 | pmol/sample |
| - | PG(40:5) | 25OH-Chol | 2.0 | BCD100322A12 | 39.7 | pmol/sample |
| - | PG(40:5) | 25OH-Chol | 4.0 | BCD100322A16 | 45.6 | pmol/sample |
| - | PG(40:5) | 25OH-Chol | 8.0 | BCD100322A20 | 59.6 | pmol/sample |
| - | PG(40:5) | 25OH-Chol | 12.0 | BCD100322A24 | 49.7 | pmol/sample |
| - | PG(40:5) | 25OH-Chol | 24.0 | BCD100322A28 | 36.6 | pmol/sample |